Compound Summary
药名: | Oleanic acid |
别名: | oleanolic acid; oleanoic,acid; oleanic acid |
分子式: | C30H48O3 |
Smiles: | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C |
成分: | HBIN037936 |
OB_score: | 8.408683 |
CAS_id: | 508-02-1 |
SymMap_id: | SMIT04506 |
TCMID_id: | 39384 |
TCMSP_id: | MOL002215 |
PubChem_id: | 10494 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE003952 | Folium Rhododendri Daurici | 满山红 | Acute bronchitis, chronic bronchitis. | |||
TCMBANKHE008356 | Radix Boehmeriae | 苎麻根 | For cooling blood and stopping bleeding | |||
TCMBANKHE004539 | Fructus Kochiae | 地肤子 | To remove damp-heat, to dispel zvind, and to relieve itching./Inhibiting the growth of various dermatomyces in vitro. | |||
TCMBANKHE005695 | Isodon amethystoides;Plectranthus nummularius;Isodon shikokiana var. occidentalis;Isodon latifolia var. reniformis | 香茶菜 | Aerial parts: To clear heat and disinhibit damp, quicken blood and dissipate stasis, resolve toxin and disperse swelling; Root: To clear heat and resolve toxin, dispel stasis and relieve pain./Aerial parts: Damp-heat jaundice, strangury, edema, swelling pain in throat, impediment pain in joints, menstrual block, mammary welling abscess, hemorrhoids, effusion of back, knocks and falls, poisonous snake bite; Root: Poisonous snake bites, swelling toxin of sore and boil, aching sinews and bones, knocks and falls, burns and scalds. | |||
TCMBANKHE007950 | Herba Lycopi;Eupatorium compositifolium | 泽兰 | 1. To invigorate blood and remove stagnation; 2. To promote urination and reduce edema/Amenorrhea, concretion and conglomeration, postpartum blood stasis abdominal pain, edema in body and face, knocks and falls, incised wound. | |||
TCMBANKHE006566 | Cortex Moutan | 牡丹皮 | To remove heat from blood, to activate blood circulation and eliminate blood stasis./Appendicitis, dysentery, hypertension, allergic rhinitis, warm heat disease with fever, macular eruption, blood ejection, spontaneous external bleeding, steaming bone tidal fever due to yin vacuity, amenorrhea due to blood stasis, dysmenorrhea, concretion and conglomeration, swelling toxin of welling abscess and sore, painful wound from knocks and falls, wind-damp-heat impediment. | |||
TCMBANKHE009016 | Herba Lycopi | 泽兰叶;泽兰 | Treatment of menstrual disorders, amenorrhea, dysmenorrhea, postpatum abdominal pain due to blood stasis, edema.1. To invigorate blood and remove stagnation; 2. To promote urination and reduce edema/Treatment of menstrual disorders, amenorrhea, dysmenorrhea, postpatum abdominal pain due to blood stasis, edema.Amenorrhea, concretion and conglomeration, postpartum blood stasis abdominal pain, edema in body and face, knocks and falls, incised wound. | |||
TCMBANKHE008697 | Caulis Aristolochiae seu Clematis | 木通 | 1. To promote water metabolism and relieve abnormal urination; 2. To clear heat and promote lactation/Acute urethritis, short voidings of reddish urine, strangury-turbidity, edema, nephritis with edema, galactostasis, heat vexation in chest, throat pain, mouth sore, tongue sores, wind-damp impediment pain, galactostasis, amenorrhea, dysmenorrhea. | |||
TCMBANKHE005630/YEM-176 | Bergenia purpurascens|Bergenia purpurascens (Hook.f.et Thoms.) Engl. | 岩白菜 | 岩白菜 | 云南民族药物志:第一卷 | To enrich and supplement, check vomiting and stanch bleeding./Vacuity with dizziness, taxation damage cough, blood ejection, hemoptysis, strangury-turbidity, vaginal discharge, toxin swelling. | 白族/拉祜族/傈僳族/苗族/纳西族/普米族/佤族/瑶族/藏族/壮族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000130 | TOP2A | TOP2; TP2A | DNA topoisomerase II alpha |
TCMBANKGE000168 | NR3C1 | GCCR; GCR; GCRST; GR; GRL | nuclear receptor subfamily 3 group C member 1 |
TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
TCMBANKGE000199 | ICAM1 | BB2; CD54; P3.58 | intercellular adhesion molecule 1 |
TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000241 | CASP8 | ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 | caspase 8 |
TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
TCMBANKGE000290 | NQO1 | DHQU; DIA4; DTD; NMOR1; NMORI; QR1 | NAD(P)H quinone dehydrogenase 1 |
TCMBANKGE000318 | HMGB1 | HMG-1; HMG1; HMG3; SBP-1 | high mobility group box 1 |
TCMBANKGE000330 | HMOX1 | HMOX1D; HO-1; HSP32; bK286B10 | heme oxygenase 1 |
TCMBANKGE000360 | CCNA2 | CCN1; CCNA | cyclin A2 |
TCMBANKGE000396 | TOP1 | TOPI | DNA topoisomerase I |
TCMBANKGE000440 | HDAC1 | GON-10; HD1; KDAC1; RPD3; RPD3L1 | histone deacetylase 1 |
TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
TCMBANKGE000568 | MET | AUTS9; DFNB97; HGFR; RCCP2; c-Met | MET proto-oncogene, receptor tyrosine kinase |
TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
TCMBANKGE000757 | PTPN2 | PTN2; PTPT; TC-PTP; TCELLPTP; TCPTP | protein tyrosine phosphatase non-receptor type 2 |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE000863 | GPBAR1 | BG37; GPCR19; GPR131; M-BAR; TGR5 | G protein-coupled bile acid receptor 1 |
TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
TCMBANKGE001042 | PTPN1 | PTP1B | protein tyrosine phosphatase non-receptor type 1 |
TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001117 | PTEN | 10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; PTENbeta; TEP1 | phosphatase and tensin homolog |
TCMBANKGE001126 | NFE2L2 | HEBP1; IMDDHH; NRF2; Nrf-2 | nuclear factor, erythroid 2 like 2 |
TCMBANKGE001131 | CASP9 | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 | caspase 9 |
TCMBANKGE001141 | PPARA | NR1C1; PPAR; PPARalpha; hPPAR | peroxisome proliferator activated receptor alpha |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001185 | PPARG | CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma | peroxisome proliferator activated receptor gamma |
TCMBANKGE001202 | MAPK14 | CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA | mitogen-activated protein kinase 14 |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE005696 | POLB | - | DNA polymerase beta |
TCMBANKGE006224 | PTGIR | IP; PRIPR | prostaglandin I2 receptor |
TCMBANKGE009472 | AKR1B10 | AKR1B11; AKR1B12; ALDRLn; ARL-1; ARL1; HIS; HSI | aldo-keto reductase family 1 member B10 |
TCMBANKGE010801 | UGT2B10 | UDPGT2B10 | UDP glucuronosyltransferase family 2 member B10 |
TCMBANKGE011077 | UGT2B11 | - | UDP glucuronosyltransferase family 2 member B11 |
TCMBANKGE012131 | NAMPT | 1110035O14Rik; PBEF; PBEF1; VF; VISFATIN | nicotinamide phosphoribosyltransferase |
TCMBANKGE013318 | PLA2G1B | PLA2; PLA2A; PPLA2 | phospholipase A2 group IB |
TCMBANKGE014055 | AMY2A | AMY2; PA | amylase alpha 2A |
TCMBANKGE014941 | DPEP1 | MBD1; MDP; RDP | dipeptidase 1 |
TCMBANKGE015090 | CYP1A2 | CP12; CYPIA2; P3-450; P450(PA) | cytochrome P450 family 1 subfamily A member 2 |